6505--Digoxin Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79724R0015
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0015 for an unrestricted procurement of Digoxin Tablets for the VA (inclusive of Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The VA will award one contract for a base period of one year with four one-year option periods. Offerors must provide the exact drug name and have a unique NDC number. The RFP will be electronically issued in commercial item format on or around April 18, 2024, with a tentative closing date of May 2, 2024.
This procurement is unrestricted, with a NAICS code of 325412. The estimated annual requirements range from 2,150 bottles of 1,000-count Digoxin 0.25mg tablets to 13,474 bottles of 100-count Digoxin 0.125mg tablets. Interested offerors should monitor SAM.gov for any solicitation updates, and questions can be emailed to the point of contact, Matthew Poulin.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0015 for an unrestricted procurement for Digoxin Tablets for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79724R0015 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 18, 2024, with a tentative closing date of May 2, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be e-mailed to Matthew.Poulin@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
DIGOXIN 0.125MG TAB
100
13,474
2
DIGOXIN 0.125MG TAB
1000
5,556
3
DIGOXIN 0.25MG TAB
100
3,133
4
DIGOXIN 0.25MG TAB
1000
2,150
Files
| File | Type | Posted |
|---|---|---|
| 36E79724R0015_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Digoxin Tablets Effective 9/17/2024 - 9/16/2025 Digoxin Tablets 0. 125mg 100 and 1, 000 count bottles Digoxin Tablets 0. 25mg 100 and 1, 000 count bottles | Award Notice | |
| 6505--Digoxin Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity